Objectives To evaluate the performance of large language models (LLMs) in risk of bias assessment and to examine whether ...

Objective To assess evidence of overall survival (OS) benefits of cancer drugs listed in China’s National Reimbursement Drug List (NRDL), the guiding standard for public insurance coverage of drugs ...

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Evidence-based medicine (EBM’s) traditional methods, especially randomised controlled trials (RCTs) and meta-analyses, along with risk-of-bias tools and checklists, have contributed significantly to ...

We have identified ‘spin’ in abstracts of randomised controlled trials (RCTs) with nonsignificant primary endpoints in psychiatry and psychology journals. This is a cross-sectional review of clinical ...

Healthcare delivery is being transformed by the rapid growth of data, advancements in artificial intelligence (AI) and other technologies. In healthcare, obtaining real-world data can be ...

Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005–2022: an observational study (12 October, 2025) ...

Objectives Endometrial cancer (EC) incidence has been rising globally, while mortality has remained stable, particularly in Nordic countries. This study aimed to explore the role of transvaginal ...

Objectives To assess the effects of digital patient decision-support tools for atrial fibrillation (AF) treatment decisions in adults with AF. Study design Systematic review and meta-analysis.

Correspondence on ‘Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine’ ...

Objectives First, investigate whether a long compared with a short abstract decreases readers’ attention. Second, investigate differences regarding perceptions of informativeness, accuracy, ...